[1] Stewart C J, Ajami N J, O'Brien J L, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study[J]. Nature, 2018, 562(7728):583-588.
[2] Vatanen T, Franzosa E A, Schwager R, et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study[J]. Nature, 2018, 562(7728):589-594.
[3] Tigchelaar E F, Zhernakova A, Dekens J A M, et al. Cohort profile:LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands:Study design and baseline characteristics[J]. BMJ Open, 2015, 5(8):e006772.
[4] Goodrich J K, Waters J L, Poole A C, et al. Human genetics shape the gut microbiome[J]. Cell, 2014, 159(4):789-799.
[5] Zeevi D, Korem T, Zmora N, et al. Personalized nutrition by prediction of glycemic responses[J]. Cell, 2015, 163(5):1079-1094.
[6] Human Microbiome Project. Microbial Reference Genomes[EB/OL].[2020-08-20]. https://www.hmpdacc.org/hmp/reference_genomes/reference_genomes.php.
[7] Almeida A, Nayfach S, Boland M, et al. A unified catalog of 204938 reference genomes from the human gut microbiome[J]. Nature Biotechnology, 2021, 39(1):105-114.
[8] Mazmanian S K, Liu C H, Tzianabos A O, et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system[J]. Cell, 2005, 122(1):107-118.
[9] Stephen M C, Michael S, Premysl B. The interplay between the intestinal microbiota and the brain[J]. Nature Reviews Microbiology, 2012, 10:735-742.
[10] Zhang D C, Chen G, Manwani D, et al. Neutrophil ageing is regulated by the microbiome[J]. Nature, 2015, 525(7570):528-532.
[11] Zhu W, Gregory J C, Org E, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk[J]. Cell, 2016, 165(1):111-124.
[12] Sampson T R, Debelius J W, Thron T, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of parkinson's disease[J]. Cell, 2016, 167(6):1469-1480.
[13] Olson C A, Vuong H E, Yano J M, et al. The gut microbiota mediates the anti-seizure effects of the ketogenic diet[J]. Cell, 2018, 173(7):1728-1741.
[14] Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, et al. Mapping human microbiome drug metabolism by gut bacteria and their genes[J]. Nature, 2019, 570(7762):462-467
[15] Iida N, Dzutsev A, Stewart C A, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment[J]. Science, 2013, 342(6161):967-970.
[16] Matson V, Fessler J, Bao R, et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients[J]. Science, 2018, 359(6371):104-108.
[17] Gopalakrishnan V, Spencer C N, Nezi L, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients[J]. Science, 2018, 359(6371):97-103.
[18] Vétizou M, Pitt J M, Daillère R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota[J]. Science, 2015, 350(6264):1079-1084.
[19] Fei N, Zhao L P. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice[J]. The ISME Journal, 2013, 7(4):880-884.
[20] Warren J R, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis[J]. Lancet, 1983, 321(8336):1273-1275.
[21] Walter J, Armet A M, Finlay B B, et al. Establishing or exaggerating causality for the gut microbiome:Lessons from human microbiota-associated rodents[J]. Cell, 2020, 180(2):221-232.
[22] 施慧琳, 王玥, 苏燕, 等. 人类微生物组产业发展态势及建议[J]. 中国生物工程杂志, 2019, 39(6):97-103.
[23] Surawicz C M, Brandt L J, Binion D G, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections[J]. American Journal of Gastroenterology, 2013, 108(4):478-498.
[24] 张发明, 张婷. 从粪菌移植到菌群移植[J]. 科学通报, 2019, 64(3):285-290.
[25] Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing[J]. Nature, 2010, 464(7285):59-65.
[26] Li J, Jia H, Cai X, et al. An integrated catalog of reference genes in the human gut microbiome[J]. Nature Biotechnology, 2014, 32(8):834-841.
[27] Qin J J, Li Y R, Cai Z M, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes[J]. Nature, 2012, 490(7418):55-60.
[28] Zou Y, Xue W, Luo G, et al. 1520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses[J]. Nature Biotechnology, 2019, 37(2):179-185.
[29] Wu M, Liu J, Li F, et al. Antibiotic-induced dysbiosis of gut microbiota impairs corneal development in postnatal mice by affecting CCR2 negative macrophage distribution[J]. Mucosal Immunology, 2020, 13:47-63.
[30] Qi X, Yun C, Sun L, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome[J]. Nature medicine, 2019, 25(8):1225-1233.
[31] Zhao L, Zhang F, Ding X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes[J]. Science, 2018, 359(6380):1151-1156.
[32] Xu J, Lian F, Zhao L, et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula[J]. Isme Journal, 2015, 9(3):552-562.
[33] Liu R X, Hong J, Xu X Q, et al. Gut microbiome and serum metabolome alterations in obesity and after weightloss intervention[J]. Nature Medicine, 2017, 23(7):859-868.
